SOUTH PLAINFIELD, NJ and LONDON--(Marketwire - October 06, 2011) - GENEWIZ, Inc., leading global provider of DNA services, announced European expansion with the launch of the GENEWIZ European Office in the United Kingdom. Andre Kotze, newly appointed European Business Development Manager, will lead GENEWIZ Europe operations.
"Expanding GENEWIZ operations into Europe is a direct result of the growing needs of the global scientific community," commented Shifang Zhang, Vice President of Corporate Development. "Having a local presence in the United Kingdom will increase accessibility, enabling GENEWIZ to offer enhanced, efficient local support and expertise, thus enriching the overall customer experience."
A leader in Sanger DNA sequencing services, GENEWIZ has quickly become a top provider of gene synthesis services, as well as molecular biology, genomic, and regulatory services. Committed to quality in all areas, GENEWIZ earned International Organization for Standardization (ISO) 9001:2008 Certification for Quality Management, a voluntary certification recognizing operational excellence and quality standards.
"Gene synthesis presents an efficient, cost-effective alternative for researchers currently performing molecular cloning," stated Kotze. "GENEWIZ's unique ability to codon-optimize sequences and design complex constructs, such as difficult templates, highly repetitive, AT-rich, and GC-rich DNA, allows us to meet all custom project requirements. In addition, fast and reliable delivery of 100% sequence-verified genes maintains customers' confidence when working with GENEWIZ."
"Marking significant growth for our global corporate development, the establishment of GENEWIZ Europe clearly demonstrates our commitment to the advancement of life sciences and the discovery of innovative solutions," remarked Zhang. "We are invigorated by this expansion and enthusiastic about what the future holds."
GENEWIZ, Inc. is a global contract research organization (CRO) specializing in DNA-based services, including DNA sequencing, gene synthesis, molecular biology, genomic, and GLP/cGMP regulatory-compliant services. The company leads the industry in research sequencing and outsourcing partnerships with pharmaceutical, clinical, biotechnology, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held, global enterprise with locations in Washington, D.C. Metro, Boston, San Diego, Beijing, China, Suzhou, China, and London, United Kingdom. For more information, please visit www.genewiz.com.